乙醛脱氢酶与消化系统肿瘤:一种潜在的精准医疗策略*

doi:10.3969/j.issn.1672-5069.2025.01.004

实用肝脏病杂志 ›› 2025, Vol. 28 ›› Issue (1): 13-16.doi: 10.3969/j.issn.1672-5069.2025.01.004

乙醛脱氢酶与消化系统肿瘤:一种潜在的精准医疗策略^*

周嘉, 周靖媛, 张飞宇, 高沿航

130021 长春市吉林大学第一医院肝胆胰内科

收稿日期:2024-10-29 出版日期:2025-01-10 发布日期:2025-02-07
通讯作者: 高沿航,E-mail: yanhang@mail.jlu.edu.cn
作者简介:周嘉,E-mail:zhoujia1213@126.com
基金资助:
^*国家自然科学基金资助项目(编号:82170602);吉林省中青年科技创新卓越人才培养项目(编号:20220508079RC);吉林省自然科学基金自由探索重点项目(编号:YDZJ202401427ZYTS)

Acetaldehyde dehydrogenase in digestive system tumors: a potential precision target for medical strategy

Zhou Jia, Zhou Jinyuan, Zhang Feiyu, et al

Department of Hepatobiliary Pancreatic Diseases, First Hospital, Jilin University, Changchun 130021, Jilin Province, China

Received:2024-10-29 Online:2025-01-10 Published:2025-02-07

摘要/Abstract

关键词: 消化系统肿瘤, 乙醛脱氢酶, 精准医学

Key words: Digestive system neoplasms, Aldehyde dehydrogenase, Precision medicine, Target

周嘉, 周靖媛, 张飞宇, 高沿航. 乙醛脱氢酶与消化系统肿瘤:一种潜在的精准医疗策略^*[J]. 实用肝脏病杂志, 2025, 28(1): 13-16.

Zhou Jia, Zhou Jinyuan, Zhang Feiyu, et al. Acetaldehyde dehydrogenase in digestive system tumors: a potential precision target for medical strategy[J]. Journal of Practical Hepatology, 2025, 28(1): 13-16.

参考文献

[1] Wang W, Wang C, Xu H, et al. Aldehyde dehydrogenase, liver disease and cancer. Int J Biol Sci, 2020, 16(6):921-934.
[2] O'Grady I, Anderson A, O'Sullivan J. The interplay of the oral microbiome and alcohol consumption in oral squamous cell carcinomas. Oral Oncol, 2020, 110: 105011.
[3] Birkova A, Hubkova B, Cizmarova B, et al. Currentview on the mechanisms of alcohol-mediated toxicity. Int J Mol Sci, 2021, 22(18):9686.
[4] Bray FA-O, Laversanne M, Sung HA-O, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2024, 74(3):229-263.
[5] Ng CS, Ong XJ, Au M, et al. ALDH2 polymorphism, alcohol intake and the attributable burden of cancer in East Asia: systematic review, meta-analysis, and modeling study. Ann Epidemiol, 2023, 85:113-120.e120.
[6] Koyanagi YA-O, Nakatochi MA-O, Namba SA-O, et al. Genetic architecture of alcohol consumption identified by a genotype-stratified GWAS and impact on esophageal cancer risk in Japanese people. Sci Adv, 2024, 10(4):eade2780.
[7] Flashner S, Shimonosono M, Tomita Y, et al. ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Carcinogenesis, 2024, 45(1-2):95-106.
[8] Moody S, Senkin S, Islam SMA, et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat Genet, 2021, 53(11): 1553-1563.
[9] Wang W, He S, Zhang R, et al. ALDH1A1 maintains the cancer stem-like cells properties of esophageal squamous cell carcinoma by activating the AKT signal pathway and interacting with β-catenin. Biomed Pharmacother, 2020, 125:109940.
[10] Laszkowska M, Rodriguez S, Kim J, et al. Heavyalcohol use is associated with gastric cancer: Analysis of the National Health and Nutrition Examination Survey From 1999 to 2010. Am J Gastroenterol, 2021, 116(5):1083-1086.
[11] Suzuki A, Katoh H, Komura D, et al. Defined lifestyle and germline factors predispose Asian populations to gastric cancer. Sci Adv, 2020, 6(19):eaav9778.
[12] Kawakami R, Mashima T, Kawata N, et al. ALDH1A3-mTOR axis as a therapeutic target for anticancer drug-tolerant persister cells in gastric cancer. Cancer Sci, 2020, 111(3):962-973.
[13] Cai Y, Zeng R, Peng J, et al. The downregulated drug-metabolism related ALDH6A1 serves as predictor for prognosis and therapeutic immune response in gastric cancer. Aging (Albany NY), 2022, 14(17):7038-7051.
[14] Zhang Z, Chen Y, Zhuo Q, et al. ALDH2 gene rs671 G ＞ a polymorphism and the risk of colorectal cancer: A hospital-based study. J Clin Lab Anal, 2022, 36(12):e24789.
[15] Wang Y, Popovic Z, Charkoftaki G, et al. Multi-omics profiling reveals cellular pathways and functions regulated by ALDH1B1 in colon cancer cells. Chem Biol Interact, 2023, 384:110714.
[16] Kang X, Jadhav S, Annaji M, et al. Advancingcancer therapy with copper/disulfiram nanomedicines and drug delivery systems. Pharmaceutics, 2023, 15(6):1567.
[17] Wei PL, Prince GMSH, Batzorig U, et al. ALDH2 promotes cancer stemness and metastasis in colorectal cancer through activating β-catenin signaling. J Cell Biochem, 2023, 124(6):907-920.
[18] Zhang H, Xia Y, Wang F, et al. Aldehydedehydrogenase 2 mediates alcohol-induced colorectal cancer immune escape through stabilizing PD-L1 expression. Adv Sci (Weinh), 2021, 8(10):2003404.
[19] Sun Y, Wang Q, Zhang Y, et al. Multigenerational maternal obesity increases the incidence of HCC in offspring via miR-27a-3p. J Hepatol, 2020, 73(3): 603-615.
[20] Chang YS, Tu SJ, Chen HD, et al. Integrated genomic analyses of hepatocellular carcinoma. Hepatol Int, 2023, 17(1):97-111.
[21] Xia P, Liu DH, Wang D, et al. SLC3A2, as an indirect target gene of ALDH2, exacerbates alcohol-associated liver cancer via the sphingolipid biosynthesis pathway. Free Radic Biol Med, 2023, 206:125-133.
[22] Liu ZY, Lin XH, Guo HY, et al. Multi-Omics profiling identifies aldehyde dehydrogenase 2 as a critical mediator in the crosstalk between Treg-mediated immunosuppression microenvironment and hepatocellular carcinoma. Int J Biol Sci, 2024, 20(7):2763-2778.
[23] Yu P, Cao S, Yang S-M, et al. RALDH1inhibition shows immunotherapeutic efficacy in hepatocellular carcinoma. Cancer Immunol Res, 2024, 12(2):180-194.
[24] Pommergaard HC, Rasmussen A, Hillingso J, et al. Aldehyde dehydrogenase expression may be a prognostic biomarker and associated with liver cirrhosis in patients resected for hepatocellular carcinoma. Surg Oncol, 2022, 40:101677.
[25] Sun J, Ding J, Shen Q, et al. Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma. J Hepatol, 2022,78(3):627–642.
[26] Shan YS, Chen LT, Wu CH, et al. No association between alcohol consumption and pancreatic cancer even among individuals genetically susceptible to the carcinogenicity of alcohol. Sci Rep, 2021, 11(1):14567.
[27] Lee JS, Lee H, Woo SM, et al. Overall survival of pancreatic ductal adenocarcinoma is doubled by Aldh7a1 deletion in the KPC mouse. Theranostics, 2021, 11(7):3472-3488.
[28] Nimmakayala RK, Leon F, Rachagani S, et al. Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma. Oncogene, 2020, 40(1):215-231.
[29] Nie S, Qian X, Shi M, et al. ALDH1A3accelerates pancreatic cancer metastasis by promoting glucose metabolism. Front Oncol, 2020, 10:915.
[30] Tan M, Meng J, Sun X, et al. EPS8 supports pancreatic cancer growth by inhibiting BMI1 mediated proteasomal degradation of ALDH7A1. Exp Cell Res, 2021, 407(1):112782.

乙醛脱氢酶与消化系统肿瘤:一种潜在的精准医疗策略^*

Acetaldehyde dehydrogenase in digestive system tumors: a potential precision target for medical strategy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

编辑推荐

Metrics

本文评价

[1]	李颖怡, 郭翠芬, 章瑞南, 汪保灿, 潘勤, 汪余勤, 曹海霞, 范建高. ALDH2 rs671基因多态性与非酒精性脂肪性肝病相关性研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 848-851.
[2]	何崇信, 徐正婕, 潘勤, 范建高. 非酒精性脂肪性肝病大鼠内生性乙醇和肝组织乙醇代谢相关酶的变化^*[J]. 实用肝脏病杂志, 2016, 19(4): 418-422.